Jeff Yass’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-42,800
| Closed | -$203K | – | 10245 |
|
|
2017
Q1 | $203K | Buy |
+42,800
| New | +$216K | ﹤0.01% | 7989 |
|
|
2016
Q3 | – | Sell |
-17,200
| Closed | -$121K | – | 9419 |
|
|
2016
Q2 | $121K | Sell |
17,200
-18,800
| -52% | -$132K | ﹤0.01% | 7934 |
|
|
2016
Q1 | $238K | Buy |
+36,000
| New | +$265K | ﹤0.01% | 7665 |
|
|
2015
Q4 | – | Sell |
-26,800
| Closed | -$316K | – | 10324 |
|
|
2015
Q3 | $316K | Sell |
26,800
-21,700
| -45% | -$240K | ﹤0.01% | 7951 |
|
|
2015
Q2 | $444K | Buy |
48,500
+200
| +0.4% | +$1.51K | ﹤0.01% | 7857 |
|
|
2015
Q1 | $300K | Buy |
+48,300
| New | +$299K | ﹤0.01% | 7982 |
|
|
2014
Q4 | – | Sell |
-33,700
| Closed | -$198K | – | 10367 |
|
|
2014
Q3 | $198K | Buy |
+33,700
| New | +$206K | ﹤0.01% | 8694 |
|
|
2014
Q2 | – | Sell |
-59,800
| Closed | -$432K | – | 10307 |
|
|
2014
Q1 | $432K | Buy |
+59,800
| New | +$413K | ﹤0.01% | 6982 |
|
Jeff Yass's JNP Position: Q3 2018 in Review
Jeff Yass sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q3 2018, closing a stake of 32,450 shares — an estimated $282K sold.
Jeff Yass first reported a position in JNP in Q1 2015 and held it in 9 quarters. The position peaked at $686K in Q3 2015. 0 funds tracked by Wall St. Rank hold JNP as of Q3 2018.
- Jeff Yass reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
- Jeff Yass sold 32,450 Juniper Pharmaceuticals, Inc. Common Stock shares in Q3 2018, an estimated $282K.
- Jeff Yass first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q1 2015 and held it in 9 quarters.
- Jeff Yass's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $686K in Q3 2015.
- 0 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2018.
Based on Susquehanna International Group's 13F filing for Q3 2018, filed 14 Nov 2018.